Novel Coronavirus (SARS-CoV-2/COVID-19)
A program at UAMS Health in Arkansas pairs medical residents, fellows and students with older adult patients for virtual social visits.
The American Medical Association announced Current Procedural Terminology codes for reporting on medical claims two COVID-19 vaccines and their administration to patients by dose.
The Centers for Medicare & Medicaid Services announced Medicare coverage for monoclonal antibody therapies, with no beneficiary cost-sharing for the duration of the COVID-19 public health emergency. CMS said the coverage will apply to bamlanivimab, the Lilly therapeutic that earned an emergency…
Headlines
Headlines
The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the…
A new report from the National Academies of Sciences, Engineering, and Medicine examines the advantages, limitations and status of certain COVID-19 diagnostic tests, including reverse transcription polymerase chain reaction tests, point-of-care tests, and next generation sequencing tests.
ECRI tested 34 disposable isolation gown models made by foreign or non-traditional suppliers and found that about half did not meet the minimum U.S. standard for liquid barrier protection, the organization said in a report released.
The Food and Drug Administration Nov. 10 issued an emergency use authorization for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab.
Congress is back in Washington, D.C., for its “lame-duck” session, in which lawmakers will take up pressing, end-of-year business. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11. It is imperative that we work to ensure that hospitals and…